High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: A retrospective comparison with non-transplantation cases

Bone Marrow Transplantation

Volumn 37, Issue 9, 2006, Pages 819-824

  Kim, H J ^a,c   Bang, S M ^b   Lee, J ^a   Kwon, H C ^c   Suh, C ^d   Lee, J H ^b   Ryoo, B Y ^e   Park, Y H ^e   Kwon, J M ^a   Oh, S Y ^a   Lee, H R ^a   Kim, K ^a   Jung, C W ^a   Park, K ^a   Kim, W S ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Dong A University College of Medicine   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Korea Cancer Center Hospital   (South Korea)

Author keywords

Autologous stem cell transplantation; Extranodal NK T cell lymphoma; High dose chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; METHOTREXATE; PREDNISOLONE; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; MALE; NATURAL KILLER T CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION; T CELL LYMPHOMA; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 33646042265     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705349     Document Type: Article

References (23)

1. Kwong YL, Chan AC, Liang R, Chiang AK, Chim CS, Chan TK et al. CD56+ NK lymphomas: Clinicopathological features and prognosis. Br J Haematol 1997; 97: 821-829.
2. Au WY, Ma SY, Chim CS, Choy C, Loong F, Lie AK et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: A single center experience of 10 years. Ann Oncol 2005; 16: 206-214.
3. Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW. Early stage nasal NK/T-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54: 182-190.
4. Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR et al. Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment. J Clin Oncol 2000; 18: 54-63.
5. Kim GE, Lee SW, Chang SK, Park HC, Pyo HR, Kin JH et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol 2001; 61: 261-269.
6. Kim WS, Song SY, Ahn YC, Ko YH, Baek CH, Kim DY et al. CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 2001; 12: 349-352.
7. Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH et al. Extranodal nasal type NK/T-cell lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005; 41: 1402-1408.
8. Lee J, Kim WS, Park YH, Park SH, Park KW, Kang JH et al. Nasal-type NK/T cell lymphoma: Clinical features and treatment outcome. Br J Cancer 2005; 92: 1226-1230.
9. Liang R, Chen F, Lee CK, Kwong YL, Chim CS, Yau CC et al. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant 1997; 19: 91-93.
10. Park BB, Kim WS, Lee J, Park KW, Kang JH, Lee SH et al. IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas. Leuk Lymphoma 2005; 46: 1743-1748.
11. Koizumi K, Fujimoto K, Haseyama Y, Endo T, Nishio M, Yokota K et al. Effective high-dose chemotherapy combined with CD34+-selected peripheral blood stem cell transplantation in a patient with cutaneous involvement of nasal NK/T-cell lymphoma. Eur J Haematol 2004; 72: 140-144.
12. Takenaka K, Shinagawa K, Maeda Y, Makita M, Kozuka T, Ashiba A et al. High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas. Leuk Lymphoma 2001; 42: 1297-1303.
13. Au WY, Lie AK, Liang R, Kwong YL, Yau CC, Cheung MM et al. Autologous stem cell transplantation for nasal NK/T-cell lymphoma: A progress report on its value. Ann Oncol 2003; 14: 1673-1676.
14. Blystad AK, Enblad G, Kvaloy S, Berglund A, Delabie J, Holte H et al. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplant 2001; 27: 711-716.
15. Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH et al. Extranodal NK/ T-Cell Lymphoma, nasal-type: A prognostic model from a retrospective multi-center study. J Clin Oncol 2006; 24: 612-618.
16. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
17. Ko YH, Cho EY, Kim JE, Lee SS, Huh JR, Chang HK et al. NK and NK-like T-cell lymphoma in extranasal sites: A comparative clinicopathological study according to site and EBV status. Histopathology 2004; 44: 480-489.
18. Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P et al. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol-a groupe d'Etude des lymphomes de l'Adulte study. J Clin Oncol 2000; 18: 3025-3030.
19. Milpied N, Deconinck E, Gaillard F, Delwail V, Foussard C, Berthou C et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004; 350: 1287-1295.
20. Bang SM, Kim Y-K, Park YH, Sohn SK, Lee J-J, Cho EK et al. High dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma. Leuk Lymphoma 2006; 46: 1599-1602.
21. Murashige N, Kami M, Kishi Y, Kim SW, Takeuchi M, Matsue K et al. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol 2005; 130: 561-567.
22. Makita M, Maeda Y, Takenaka K, Shinagawa K, Sunami K, Hiramatsu Y et al. Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions. Int J Hematol 2002; 76: 94-97.
23. Suzuki R, Suzumiya J, Nakamura S, Kagami Y, Kameoka JI, Sakai C et al. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant 2006; 37: 425-431.